DE69505391T2 - Implantierte vorrichtung mit tumorzellen zur behandlung von krebs - Google Patents

Implantierte vorrichtung mit tumorzellen zur behandlung von krebs

Info

Publication number
DE69505391T2
DE69505391T2 DE69505391T DE69505391T DE69505391T2 DE 69505391 T2 DE69505391 T2 DE 69505391T2 DE 69505391 T DE69505391 T DE 69505391T DE 69505391 T DE69505391 T DE 69505391T DE 69505391 T2 DE69505391 T2 DE 69505391T2
Authority
DE
Germany
Prior art keywords
cells
boundary
cancer
patient
tumor cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69505391T
Other languages
English (en)
Other versions
DE69505391D1 (de
Inventor
Robin Geller
James Brauker
William Johnston
Steven Levon
David Maryanov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of DE69505391D1 publication Critical patent/DE69505391D1/de
Publication of DE69505391T2 publication Critical patent/DE69505391T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
DE69505391T 1994-07-08 1995-06-29 Implantierte vorrichtung mit tumorzellen zur behandlung von krebs Expired - Fee Related DE69505391T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27218994A 1994-07-08 1994-07-08
US46224995A 1995-06-05 1995-06-05
PCT/US1995/008151 WO1996001611A1 (en) 1994-07-08 1995-06-29 Implanted device containing tumor cells for the treatment of cancer

Publications (2)

Publication Number Publication Date
DE69505391D1 DE69505391D1 (de) 1998-11-19
DE69505391T2 true DE69505391T2 (de) 1999-06-17

Family

ID=26955354

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69505391T Expired - Fee Related DE69505391T2 (de) 1994-07-08 1995-06-29 Implantierte vorrichtung mit tumorzellen zur behandlung von krebs

Country Status (13)

Country Link
EP (1) EP0769932B1 (de)
JP (1) JPH10502638A (de)
KR (1) KR970704410A (de)
CN (1) CN1157560A (de)
AT (1) ATE172099T1 (de)
AU (1) AU699405B2 (de)
CA (1) CA2194555C (de)
DE (1) DE69505391T2 (de)
DK (1) DK0769932T3 (de)
ES (1) ES2125630T3 (de)
IL (1) IL114482A0 (de)
NO (1) NO970054L (de)
WO (1) WO1996001611A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297331B2 (en) 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US6224912B1 (en) 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
US6558321B1 (en) 1997-03-04 2003-05-06 Dexcom, Inc. Systems and methods for remote monitoring and modulation of medical devices
US8527026B2 (en) 1997-03-04 2013-09-03 Dexcom, Inc. Device and method for determining analyte levels
US6741877B1 (en) 1997-03-04 2004-05-25 Dexcom, Inc. Device and method for determining analyte levels
US6001067A (en) * 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US6862465B2 (en) 1997-03-04 2005-03-01 Dexcom, Inc. Device and method for determining analyte levels
CA2321101C (en) * 1998-02-20 2014-12-09 University Of Miami Modified heat shock protein-antigenic peptide complex
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
NO983911D0 (no) 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
CA2362578A1 (en) 1999-02-09 2000-08-17 Kam Leong Tumor vaccines
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US6702857B2 (en) 2001-07-27 2004-03-09 Dexcom, Inc. Membrane for use with implantable devices
US20030032874A1 (en) 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7613491B2 (en) 2002-05-22 2009-11-03 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US7226978B2 (en) 2002-05-22 2007-06-05 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
JP4708342B2 (ja) 2003-07-25 2011-06-22 デックスコム・インコーポレーテッド 埋設可能な装置に用いる酸素増大膜システム
US9763609B2 (en) 2003-07-25 2017-09-19 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8615282B2 (en) 2004-07-13 2013-12-24 Dexcom, Inc. Analyte sensor
EP1711790B1 (de) 2003-12-05 2010-09-08 DexCom, Inc. Kalibrationsmethoden für einen kontinuierlich arbeitenden analytsensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
WO2006127694A2 (en) 2004-07-13 2006-11-30 Dexcom, Inc. Analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US7654956B2 (en) 2004-07-13 2010-02-02 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US20200037874A1 (en) 2007-05-18 2020-02-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20080306434A1 (en) 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US9452258B2 (en) 2007-10-09 2016-09-27 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
EP2257301B1 (de) 2008-03-03 2014-01-22 The University of Miami Auf allogenen krebszellen basierende immuntherapie
CA2718884C (en) 2008-03-20 2016-11-22 University Of Miami Heat shock protein gp96 vaccination and methods of using same
US11730407B2 (en) 2008-03-28 2023-08-22 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8682408B2 (en) 2008-03-28 2014-03-25 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8583204B2 (en) 2008-03-28 2013-11-12 Dexcom, Inc. Polymer membranes for continuous analyte sensors
EP2482724A2 (de) 2009-09-30 2012-08-08 Dexcom, Inc. Transkutaner analytsensor
AU2016215175B2 (en) 2015-02-06 2021-09-16 Heat Biologics, Inc. Vector co-expressing vaccine and costimulatory molecules
US11666649B2 (en) 2016-10-11 2023-06-06 University Of Miami Vectors and vaccine cells for immunity against Zika virus
US11548930B2 (en) 2017-04-04 2023-01-10 Heat Biologics, Inc. Intratumoral vaccination
CN111246797A (zh) 2017-10-24 2020-06-05 德克斯康公司 预连接分析物传感器
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2117647B (en) * 1982-04-06 1985-06-19 James Victor Watson Medical treatment and apparatus therefor

Also Published As

Publication number Publication date
NO970054L (no) 1997-03-10
WO1996001611A1 (en) 1996-01-25
CN1157560A (zh) 1997-08-20
AU699405B2 (en) 1998-12-03
AU2912895A (en) 1996-02-09
EP0769932A1 (de) 1997-05-02
JPH10502638A (ja) 1998-03-10
ES2125630T3 (es) 1999-03-01
EP0769932B1 (de) 1998-10-14
NO970054D0 (no) 1997-01-07
CA2194555A1 (en) 1996-01-25
CA2194555C (en) 2002-01-29
IL114482A0 (en) 1995-11-27
KR970704410A (ko) 1997-09-06
DE69505391D1 (de) 1998-11-19
ATE172099T1 (de) 1998-10-15
DK0769932T3 (da) 1999-06-23

Similar Documents

Publication Publication Date Title
DE69505391T2 (de) Implantierte vorrichtung mit tumorzellen zur behandlung von krebs
DE69631387D1 (de) Vorrichtung zur implantation von filamenten in den körper
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
MY111196A (en) Therapeutic aplication of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
DE3166658D1 (en) Combined bone implant and tissue retention element
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DK0540670T3 (da) Fremgangsmåde til fremstilling af tværbundne polyaminer
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
FR2657259B1 (de)
DE59102505D1 (de) Vorrichtung zur Rekombination von Wasserstoff und Sauerstoff.
DE69715000D1 (de) Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens
ATE29137T1 (de) Verfahren zur herstellung zell- und geweberegenerierender stoffe.
DE59008901D1 (de) Vorrichtung zur Erstellung von medizinischen, insbesondere zahnmedizinischen, Prothetik- Passkörpern.
DE69012808D1 (de) Vorrichtung zur behandlung von lebenden fischen und fischbrut und deren verwendung.
DE69111722D1 (de) Vorrichtung zur elektrolytischen Behandlung.
MX9700148A (es) Dispositivo implantable que contiene celulas de tumor para el tratamiento del cancer.
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
EP0049341A3 (en) Process for conditioning and implanting alloplastic implants and organ grafts, as well as for pretreating the recipient
DE3766662D1 (de) Vorrichtung zur kompaktierung und volumenreduktion.
DE69108116D1 (de) Vorrichtung zur Stimulation lebenden Gewebes.
DE69111457D1 (de) Katheter und vorrichtung zur behandlung, insbesondere von lungenembolien.
EP0646010A4 (de) Verwendung von müllerscher inhibierender substanz zur behandlung von tumoren und zur modulation der expression von klasse 1-haupthistokompatibilitätsantigen.
EP0136093A3 (de) Antikrebsfaktoren
ATE136463T1 (de) Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen
FI113153B (fi) Solukasvunsäätelijä

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee